| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |